Description
GSK-2334470 is a selective inhibitor of PDK1 that exhibits anticancer activity in in vitro models. GSK-2334470 inhibits T-loop phosphorylation of SGK and S6K1, Akt and Akt substrates GSK3, FoxO, and PRAS40, and ERK substrate RSK2.
Product Unit Size | Cost | Quantity | Stock |
---|
GSK-2334470 is a selective inhibitor of PDK1 that exhibits anticancer activity in in vitro models. GSK-2334470 inhibits T-loop phosphorylation of SGK and S6K1, Akt and Akt substrates GSK3, FoxO, and PRAS40, and ERK substrate RSK2.
Cas No. | 1227911-45-6 |
---|---|
Purity | ≥99%, ≥99%ee |
Formula | C25H34N8O |
Formula Wt. | 462.59 |
Chemical Name | (3S,6R)-1-[6-(3-amino-1H-indazol-6-yl)-2-(methylamino)pyrimidin-4-yl]-N-cyclohexyl-6-methylpiperidine-3-carboxamide |
IUPAC Name | (3S,6R)-1-[6-(3-amino-1H-indazol-6-yl)-2-(methylamino)pyrimidin-4-yl]-N- cyclohexyl-6-methylpiperidine-3-carboxamide |
Solubility | DMSO 28 mg/mL (64.6 mM) Water Insoluble Ethanol Insoluble |
Appearance | off-white powder |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet |
Najafov A, Sommer EM, Axten JM, et al. Characterization of GSK2334470, a novel and highly specific inhibitor of PDK1. Biochem J. 2011 Jan 15;433(2):357-69. PMID: 21087210.
Organosulfur found in garlic.
M3 mAChR antagonist.
EP4 receptor antagonist
Topoisomerase II inhibitor, RPA modulator.
Endogenous bile acid; FXR agonist.
Endogenous peptide hormone fragment, involved i...
Polyene macrolide, induces pore formation in fu...
Active metabolite of losartan
5-HT2 antagonist, SERT and NET inhibitor, hERG ...
Mixture of terpene lactones found in Ginkgo.
Chloramphenicol derivative; protein translation...
Endogenous coenzyme, unit of cellular energy, r...
Fluorinated aminopropyl carbazole, neuroprotect...
GABA derivative; GABA-B agonist.
Inhibitor of ATM.
Adenosine A2A antagonist.
SYK/JAK inhibitor
Diterpene component of vitamin A, differentiati...
Thrombin inhibitor.
RXR agonist.